GRI Bio Inc. (GRI) — Financial Flexibility Index
GRI Bio Inc. (GRI) has a Financial Flexibility Index of -4.64x as of March 2026. Free cash flow of $-3.69 Million (operating CF $-3.69 Million minus capex $0.00) represents -5% of total liabilities ($794.00K). Check GRI capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GRI Bio Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for GRI Bio Inc. across 8 annual periods. See GRI Bio Inc. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for GRI Bio Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for GRI Bio Inc.. For the full company profile including market capitalisation, see GRI company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.83x | $-10.18 Million | $-10.19 Million | $2.66 Million | ▲ +24.1% |
| 2024 | -5.04x | $-8.61 Million | $-8.61 Million | $1.71 Million | ▼ -51.5% |
| 2023 | -3.33x | $-8.98 Million | $-8.99 Million | $2.70 Million | ▼ -518.1% |
| 2022 | -0.54x | $-1.08 Million | $-1.08 Million | $2.01 Million | ▼ -214.4% |
| 2021 | -0.17x | $-847.00K | $-847.00K | $4.94 Million | ▲ +88.9% |
| 2020 | -1.54x | $-3.70 Million | $-3.71 Million | $2.41 Million | ▲ +43.4% |
| 2019 | -2.72x | $-2.88 Million | $-2.88 Million | $1.06 Million | ▲ +44.2% |
| 2018 | -4.87x | $-2.37 Million | $-2.37 Million | $486.29K | — |